Pharma excessive pricing probe spreads to South Africa

South Africa’s antitrust enforcer has opened wide-ranging investigations of Roche, Pfizer and Aspen, accusing the pharmaceutical companies of illegal unilateral conduct affecting the price and availability of cancer drugs.

Get unlimited access to all Global Competition Review content